InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, launches Immune Response Template (IRT) version 3.7.0. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system.
Generally, IRT is based on two main components. On the one hand, it is a fully-fledged database including a wide variety of features covering the immune system. On the other hand, it comprises Navigator that provides intuitive interface to interact with IRT Database. Thus, a modeler can apply calibrated submodels exported from IRT as building blocks to simplify the model development process.
IRT is a part of InSysBio’s QSP software infrastructure being under constant upgrade. IRT v.3.7.0 gets a range of new features:
Veronika Musatova, Head of IRT development team, comments on the new version, “This update brings a meaningful improvement to the Immunological Synapse submodels. Introducing synthesis and degradation of each surface molecule, we add important biological dynamics, aligning the submodels more closely with real cellular behavior. These processes are commonly used in the development of QSP models to capture turnover and regulation mechanisms.”
To learn the full content of Immune Response Template, please visit irt.insysbio.com
To get demo access to IRT, please click “sign in” or “user account” on irt.insysbio.com
To get more information on any tool or leave your feedback, please feel free to contact us: support@insysbio.com
About InSysBio
InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s cutting-edge QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry and innovative biotech companies. For more information about InSysBio, its solutions and services, visit www.insysbio.com
| ← | March 2019 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
|
2
|
3
| ||||
|
4
1.
04 Mar 2019 15:40
12th InSysBio Annual Internal Scientific Meeting
20-22 February 2019 InSysBio company held the 12th Annual Internal Scientific Meeting. Results of the last year and plans for the ongoing year were discussed.
|
5
|
6
|
7
|
8
|
9
|
10
|
|
11
|
12
|
13
1.
13 Mar 2019 15:50
Tatiana Karelina on TV
Tatiana Karelina, Head of the Alzheimer’s Disease modeling group at InSysBio participated in the Russian TV show «Us and science. Science and us».
|
14
|
15
|
16
|
17
|
|
18
|
19
|
20
|
21
|
22
1.
22 Mar 2019 14:58
InSysBio to present at AACR Annual Meeting 2019
InSysBio announces their participation at American Association for Cancer Research Annual Meeting 2019 being held on March 29 – April 3 in Atlanta, GA
|
23
|
24
|
|
25
|
26
1.
26 Mar 2019 19:51
InSysBio to present at PEGS Boston
InSysBio announces their participation at 15th Essential Protein Engineering Summit being held on April 8-12 in Boston, MA.
|
27
|
28
|
29
|
30
|
31
|
Thank you for your message! We will get back to you shortly.
